About this trial
The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age at inclusion between =18 and =65 years old
Signed informed consent and ability to comply with study and follow-up.
Confirmed MS diagnosis according to McDonald criteria (2017)
Expanded Disability Status Scale EDSS = 6
Disqualifiers
Participants with a relapse within the past 3 months before the inclusion
Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
Trial population
Patients with MS will be recruited from the CHU Lille. Patients will be informed of this study by the Investigator during routine follow-up visits. The Investigator will also connect with local patient organizations and share a flyer. This flyer will also be displayed within the Neurology and Neurological Rehabilitation departments of the hospital and diffused to the hospital staff.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
description of ambulation pattern in controlled environment in people living with multiple sclerosis (pwMS) with different disease severities
Measurement of daily life-like activity movements by Optical Motion Capture, pressure sensitive walkway and wearable sensors